EPISODE · Jun 4, 2026 · 12 MIN
The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026
from DX Today | No-Hype Podcast & News About AI & DX
The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026 More than 200 AI discovered drug candidates are now in human trials, yet not one has been approved. We dig into Insilico Medicine's Rentosertib, Relay Therapeutics' Zovegalisib, Eli Lilly's 2.75 billion dollar Insilico deal, and the LillyPod supercomputer to ask whether 2026 through 2028 is the make or break window for the first FDA approval of an AI designed medicine. Hosted by Chris and Laura. The DX Today Podcast brings you daily deep dives into the most consequential stories in the AI ecosystem. Send us fan mail: https://dxtoday.com/contact #AI #DrugDiscovery #Biotech #HealthcareAI #Pharma
Embed this episode
What this episode covers
The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026 More than 200 AI discovered drug candidates are now in human trials, yet not one has been approved. We dig into Insilico Medicine's Rentosertib, Relay Therapeutics' Zovegalisib, Eli Lilly's 2.75 billion dollar Insilico deal, and the LillyPod supercomputer to ask whether 2026 through 2028 is the make or break window for the first FDA approval of an AI designed medici...
Ready to play
The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.